Viewing Study NCT02504359


Ignite Creation Date: 2025-12-24 @ 2:33 PM
Ignite Modification Date: 2026-01-25 @ 1:52 AM
Study NCT ID: NCT02504359
Status: COMPLETED
Last Update Posted: 2020-11-23
First Post: 2015-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
Sponsor: OHSU Knight Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Plasma Cell Leukemia View
None Recurrent Plasma Cell Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BEAM View
None allogeneic View
None myeloma View
None ixazomib View
None transplant View
None plasma cell leukemia View